Trial Profile
A Study Assessing Impact of Perioperative Bevacizumab on Different Outcomes in Patients Following Lung Metastasectomy for Colorectal Cancer according to the Mutational Status
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Oct 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 25 Oct 2017 New trial record